Hsbc Holdings PLC Haemonetics Corp Call Options Transaction History

Hsbc Holdings PLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 12, 2024	BUY	$81.24 - $97.37 $6.47 Million - $7.76 Million	79,700 Added 1449.09%	85,200 $7.05 Million
Q1 2024 May 15, 2024	SELL	$71.24 - $85.35 $1.77 Million - $2.13 Million	-24,900 Reduced 81.91%	5,500 $469,000
Q4 2023 Feb 12, 2024	SELL	$80.59 - $92.61 $5.46 Million - $6.28 Million	-67,800 Reduced 69.04%	30,400 $2.6 Million
Q3 2023 Nov 13, 2023	BUY	$82.56 - $93.49 $3.98 Million - $4.51 Million	48,200 Added 96.4%	98,200 $8.8 Million
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $2.92 Million - $3.64 Million	40,200 Added 410.2%	50,000 $4.14 Million
Q4 2022 Feb 14, 2023	BUY	$73.85 - $86.14 $716,345 - $835,558	9,700 Added 9700.0%	9,800 $770,000
Q3 2022 Nov 14, 2022	BUY	$63.3 - $78.66 $6,330 - $7,866	100 New	100 $7,000

337

55.2M

383K

45.1K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.1B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.